SEC
SlamSEC
SearchBrowseEarnings

IMMUTEP Ltd

Nasdaq:IMMPOTC:PRRUF
Pharmaceutical Preparations·SYDNEY,, C3
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Governanceproxy statements · beneficial ownership

Ownership Filings

7 shown
FiledFormDescription
11/12/24SC 13G/ASC 13G/A→
2/9/24SC 13G/ASC 13G/A→
2/9/23SC 13G/ASC 13G/A→
2/9/22SC 13GSC 13G→
2/11/21SC 13G/AAMENDMENT TO FORM SC 13G→
2/14/20SC 13G/AAMENDMENT TO FORM SC 13G→
↓

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine.